skip navigation links
National Cancer Institute
EVS Logo NCI Term Browser Enterprise Vocabulary Services
Terminologies Value Sets Mappings
Version: 17.06d (Release date: 2017-06-26)
SearchBox Top
SearchBox Bottom
Levonantradol (Code C1385)

Terms & Properties Synonym Details Relationships Mapping View All  
Terms & Properties

Preferred Name: Levonantradol

Definition: A synthetic cannabinoid analogue of delta (9)-tetrahydrocannabinol (delta(9)-THC) with antiemetic and anti-analgesic properties. Although its precise mechanism of action is unknown, levonantradol appears to bind and activate the cannabinoid receptors CB1 and/or CB2. (NCI04)

Label: Levonantradol

NCI Thesaurus Code: C1385 (Search for linked caDSR metadata)  (search value sets)

NCI Metathesaurus Link: C0125660  (see NCI Metathesaurus info)

Synonyms & Abbreviations: (see Synonym Details)
Levonantradol
LEVONANTRADOL
Levonantradol HCl

External Source Codes: 
CAS Registry Number 71048-87-8 (see NLM ChemIDplus info)
FDA UNII Code 03S640ADSK
PDQ Closed Trial Search ID 39490
PDQ Open Trial Search ID 39490 (check for NCI PDQ open clinical trial info)
UMLS CUI C0125660

Other Properties:
     Name Value (qualifiers indented underneath)
Chemical_Formula C27H35NO4
code C1385
Contributing_Source FDA
Legacy_Concept_Name Levonantradol
Semantic_Type Organic Chemical
Semantic_Type Pharmacologic Substance

Additional Concept Data: 
Defined Fully by Roles: No  

URL: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C1385

Mainbox Bottom